Annual Non Current Assets
$12.94 B
+$4.35 B+50.67%
December 31, 2024
Summary
- As of March 12, 2025, VRTX annual long term assets is $12.94 billion, with the most recent change of +$4.35 billion (+50.67%) on December 31, 2024.
- During the last 3 years, VRTX annual non current assets has risen by +$9.06 billion (+234.12%).
- VRTX annual non current assets is now at all-time high.
Performance
VRTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$12.94 B
+$500.70 M+4.03%
December 31, 2024
Summary
- As of March 12, 2025, VRTX quarterly long term assets is $12.94 billion, with the most recent change of +$500.70 million (+4.03%) on December 31, 2024.
- Over the past year, VRTX quarterly non current assets has increased by +$4.35 billion (+50.67%).
- VRTX quarterly non current assets is now at all-time high.
Performance
VRTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
VRTX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.7% | +50.7% |
| 3 y3 years | +234.1% | +191.7% |
| 5 y5 years | +270.1% | +191.7% |
VRTX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +234.1% | at high | +234.1% |
| 5 y | 5-year | at high | +270.1% | at high | +275.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Vertex Pharmaceuticals Incorporated Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $9.60 B(-32.2%) | $12.94 B(+4.0%) |
| Sep 2024 | - | $12.44 B(+11.1%) |
| Jun 2024 | - | $11.19 B(+5.3%) |
| Mar 2024 | - | $10.63 B(+23.8%) |
| Dec 2023 | $14.14 B(+6.9%) | $8.59 B(+22.1%) |
| Sep 2023 | - | $7.03 B(+8.6%) |
| Jun 2023 | - | $6.48 B(+7.8%) |
| Mar 2023 | - | $6.01 B(+22.2%) |
| Dec 2022 | $13.23 B(+38.4%) | $4.92 B(+10.8%) |
| Sep 2022 | - | $4.44 B(+8.7%) |
| Jun 2022 | - | $4.08 B(+4.7%) |
| Mar 2022 | - | $3.89 B(+0.6%) |
| Dec 2021 | $9.56 B(+17.5%) | $3.87 B(+2.8%) |
| Sep 2021 | - | $3.77 B(+0.1%) |
| Jun 2021 | - | $3.76 B(+5.3%) |
| Mar 2021 | - | $3.58 B(-1.2%) |
| Dec 2020 | $8.13 B(+68.6%) | $3.62 B(-5.8%) |
| Sep 2020 | - | $3.84 B(+9.1%) |
| Jun 2020 | - | $3.52 B(+2.2%) |
| Mar 2020 | - | $3.45 B(-1.4%) |
| Dec 2019 | $4.82 B(+25.5%) | $3.50 B(+27.7%) |
| Sep 2019 | - | $2.74 B(+17.9%) |
| Jun 2019 | - | $2.32 B(-1.6%) |
| Mar 2019 | - | $2.36 B(-1.8%) |
| Dec 2018 | $3.84 B(+45.1%) | $2.40 B(+157.2%) |
| Sep 2018 | - | $934.23 M(+0.7%) |
| Jun 2018 | - | $927.96 M(+1.8%) |
| Mar 2018 | - | $911.86 M(+1.7%) |
| Dec 2017 | $2.65 B(+44.6%) | $897.05 M(+3.1%) |
| Sep 2017 | - | $870.35 M(-21.2%) |
| Jun 2017 | - | $1.11 B(+2.8%) |
| Mar 2017 | - | $1.07 B(+0.9%) |
| Dec 2016 | $1.83 B(+30.2%) | $1.07 B(-3.8%) |
| Sep 2016 | - | $1.11 B(+1.2%) |
| Jun 2016 | - | $1.09 B(+0.9%) |
| Mar 2016 | - | $1.09 B(-0.6%) |
| Dec 2015 | $1.41 B(-9.0%) | $1.09 B(+1.6%) |
| Sep 2015 | - | $1.07 B(-0.4%) |
| Jun 2015 | - | $1.08 B(+33.6%) |
| Mar 2015 | - | $807.62 M(+2.5%) |
| Dec 2014 | $1.55 B(-2.6%) | $788.17 M(+4.3%) |
| Sep 2014 | - | $755.99 M(-1.9%) |
| Jun 2014 | - | $770.44 M(+0.5%) |
| Mar 2014 | - | $766.78 M(+5.0%) |
| Dec 2013 | $1.59 B(-0.1%) | $730.47 M(-21.8%) |
| Sep 2013 | - | $934.12 M(+7.6%) |
| Jun 2013 | - | $867.74 M(+5.0%) |
| Mar 2013 | - | $826.45 M(-29.3%) |
| Dec 2012 | $1.59 B(+19.4%) | $1.17 B(+7.9%) |
| Sep 2012 | - | $1.08 B(+7.2%) |
| Jun 2012 | - | $1.01 B(+11.2%) |
| Mar 2012 | - | $909.73 M(+4.2%) |
| Dec 2011 | $1.33 B(+25.9%) | $873.03 M(+3.2%) |
| Sep 2011 | - | $846.17 M(-9.6%) |
| Jun 2011 | - | $935.98 M(+40.6%) |
| Mar 2011 | - | $665.51 M(-0.4%) |
| Dec 2010 | $1.06 B(-19.1%) | $668.41 M(+0.9%) |
| Sep 2010 | - | $662.39 M(+2.0%) |
| Jun 2010 | - | $649.65 M(+0.9%) |
| Mar 2010 | - | $643.53 M(-0.8%) |
| Dec 2009 | $1.31 B(+50.7%) | $648.46 M(-1.7%) |
| Sep 2009 | - | $659.42 M(+0.4%) |
| Jun 2009 | - | $657.12 M(-1.0%) |
| Mar 2009 | - | $663.71 M(+487.9%) |
| Dec 2008 | $867.58 M(+74.6%) | $112.90 M(-1.4%) |
| Sep 2008 | - | $114.54 M(+1.2%) |
| Jun 2008 | - | $113.18 M(+7.2%) |
| Mar 2008 | - | $105.57 M(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $496.85 M(-35.6%) | $104.63 M(-6.5%) |
| Sep 2007 | - | $111.87 M(-9.4%) |
| Jun 2007 | - | $123.41 M(-4.0%) |
| Mar 2007 | - | $128.56 M(-14.4%) |
| Dec 2006 | $771.41 M(+100.3%) | $150.17 M(-5.8%) |
| Sep 2006 | - | $159.41 M(-7.8%) |
| Jun 2006 | - | $172.89 M(+11.8%) |
| Mar 2006 | - | $154.61 M(-5.7%) |
| Dec 2005 | $385.06 M(-3.9%) | $163.94 M(+29.9%) |
| Sep 2005 | - | $126.24 M(-4.1%) |
| Jun 2005 | - | $131.59 M(-1.9%) |
| Mar 2005 | - | $134.20 M(-7.3%) |
| Dec 2004 | $400.64 M(-32.5%) | $144.81 M(+2.3%) |
| Sep 2004 | - | $141.53 M(-5.5%) |
| Jun 2004 | - | $149.84 M(+10.4%) |
| Mar 2004 | - | $135.75 M(+3.9%) |
| Dec 2003 | $593.81 M(-9.6%) | $130.60 M(-1.4%) |
| Sep 2003 | - | $132.40 M(-4.2%) |
| Jun 2003 | - | $138.21 M(-2.9%) |
| Mar 2003 | - | $142.33 M(-10.6%) |
| Dec 2002 | $656.57 M(-15.4%) | $159.15 M(+1.1%) |
| Sep 2002 | - | $157.42 M(+3.0%) |
| Jun 2002 | - | $152.87 M(+0.8%) |
| Mar 2002 | - | $151.73 M(+1.8%) |
| Dec 2001 | $776.09 M(+54.2%) | $149.04 M(-69.8%) |
| Sep 2001 | - | $493.95 M(+13.2%) |
| Jun 2001 | - | $436.36 M(+0.0%) |
| Mar 2001 | - | $436.27 M(-0.4%) |
| Dec 2000 | $503.29 M(+157.8%) | $437.85 M(+735.9%) |
| Sep 2000 | - | $52.38 M(+22.4%) |
| Jun 2000 | - | $42.80 M(-0.9%) |
| Mar 2000 | - | $43.18 M(+15.9%) |
| Dec 1999 | $195.20 M(-21.5%) | $37.25 M(+21.3%) |
| Sep 1999 | - | $30.70 M(+12.5%) |
| Jun 1999 | - | $27.30 M(+18.7%) |
| Mar 1999 | - | $23.00 M(+30.7%) |
| Dec 1998 | $248.70 M(-11.7%) | $17.60 M(+3.5%) |
| Sep 1998 | - | $17.00 M(0.0%) |
| Jun 1998 | - | $17.00 M(+7.6%) |
| Mar 1998 | - | $15.80 M(+12.9%) |
| Dec 1997 | $281.60 M(+113.0%) | $14.00 M(+6.1%) |
| Sep 1997 | - | $13.20 M(+2.3%) |
| Jun 1997 | - | $12.90 M(+0.8%) |
| Mar 1997 | - | $12.80 M(+13.3%) |
| Dec 1996 | $132.20 M(+50.4%) | $11.30 M(+1.8%) |
| Sep 1996 | - | $11.10 M(-3.5%) |
| Jun 1996 | - | $11.50 M(-1.7%) |
| Mar 1996 | - | $11.70 M(+5.4%) |
| Dec 1995 | $87.90 M(-17.8%) | $11.10 M(+4.7%) |
| Sep 1995 | - | $10.60 M(-2.8%) |
| Jun 1995 | - | $10.90 M(-2.7%) |
| Mar 1995 | - | $11.20 M(+20.4%) |
| Dec 1994 | $106.90 M(+101.3%) | $9.30 M(-3.1%) |
| Sep 1994 | - | $9.60 M(+12.9%) |
| Jun 1994 | - | $8.50 M(+4.9%) |
| Mar 1994 | - | $8.10 M(+2.5%) |
| Dec 1993 | $53.10 M(+20.7%) | $7.90 M(0.0%) |
| Sep 1993 | - | $7.90 M(0.0%) |
| Jun 1993 | - | $7.90 M(-1.3%) |
| Mar 1993 | - | $8.00 M(+14.3%) |
| Dec 1992 | $44.00 M(-14.9%) | $7.00 M(+14.8%) |
| Sep 1992 | - | $6.10 M(-4.7%) |
| Jun 1992 | - | $6.40 M(+1.6%) |
| Mar 1992 | - | $6.30 M(+16.7%) |
| Dec 1991 | $51.70 M(+1023.9%) | $5.40 M(+8.0%) |
| Sep 1991 | - | $5.00 M(+4.2%) |
| Jun 1991 | - | $4.80 M(+4.3%) |
| Dec 1990 | $4.60 M | $4.60 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual long term assets?
- What is the all time high annual non current assets for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual non current assets year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly long term assets?
- What is the all time high quarterly non current assets for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly non current assets year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual long term assets?
The current annual non current assets of VRTX is $12.94 B
What is the all time high annual non current assets for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual long term assets is $12.94 B
What is Vertex Pharmaceuticals Incorporated annual non current assets year-on-year change?
Over the past year, VRTX annual long term assets has changed by +$4.35 B (+50.67%)
What is Vertex Pharmaceuticals Incorporated quarterly long term assets?
The current quarterly non current assets of VRTX is $12.94 B
What is the all time high quarterly non current assets for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly long term assets is $12.94 B
What is Vertex Pharmaceuticals Incorporated quarterly non current assets year-on-year change?
Over the past year, VRTX quarterly long term assets has changed by +$4.35 B (+50.67%)